S. Bahrami
YOU?
Author Swipe
View article: Optimizing premedications for multiple sclerosis patients treated with ocrelizumab: A randomized controlled trial
Optimizing premedications for multiple sclerosis patients treated with ocrelizumab: A randomized controlled trial Open
Background Multiple sclerosis (MS), a chronic neurological disease, is typically managed with disease-modifying therapies (DMTs) to reduce relapse rates and slow disease progression. Some of these DMTs can cause infusion-related reactions …
View article: Parkinsonism as an initial presentation of Creutzfeldt‐Jakob disease: A case report and review of literature
Parkinsonism as an initial presentation of Creutzfeldt‐Jakob disease: A case report and review of literature Open
Key Clinical Message Creutzfeldt‐Jakob disease (CJD) is a rapidly progressive, fatal neurodegenerative disorder. This case highlights parkinsonism as a rare initial manifestation of sporadic CJD (sCJD), emphasizing the need for heightened …